CYH - Community Health Systems, Inc.

Community Health Systems operates general acute-care hospitals, offering inpatient and outpatient hospital services including emergency care, surgery, cardiology, and women's health across its network of owned and leased hospitals. The business model is fee-for-service and managed care contracting, serving patients in non-urban and mid-sized markets across the United States, with revenue driven by Medicare, Medicaid, and commercial insurance reimbursements. CYH generates approximately $12B in annual revenue, operating roughly 70 hospitals concentrated in the southern and southeastern United States. The company has been in a multi-year deleveraging phase after a major acquisition-driven expansion, selling off hospitals to reduce a substantial long-term debt load.

Past Year Trends

• CYH's FY2025 net operating revenues declined 1.2% year over year to $12.485 billion due to hospital divestitures, while same-store net revenues grew 4.6% driven by rate increases and improved acuity, illustrating that portfolio shrinkage masked underlying volume recovery. (Neutral)
• CYH swung from a $(516) million net loss in FY2024 to a $509 million net income in FY2025, and reduced total leverage from 7.4x to 6.6x by redeeming $445 million of its 10.875% Senior Secured Notes due 2032 during 2025. (Bullish)
• Q1 2026 adjusted EBITDA fell 17.8% year over year to $309 million (10.4% margin), with management attributing the miss to commercial and ACA exchange patient volumes and payer mix coming in below internal plan — the sharpest quarterly EBITDA margin contraction in recent periods. (Bearish)

Next Year Trends

• The April 1, 2026 close of the $459 million Crestwood Medical Center sale to Huntsville Hospital Health System, combined with a broader divestiture program targeting over $1.5 billion in total proceeds, is expected to compress full-year 2026 revenue to the $11.6B–$12.0B guidance range versus $12.485 billion in 2025, even as proceeds are used for debt reduction. (Neutral)
• A 4% Medicare inpatient base rate increase scheduled for H2 2026 is the primary identified rate tailwind in CYH's 2026 guidance, and management has explicitly flagged it as the driver of expected back-half weighted EBITDA improvement toward the $1.34B–$1.49B full-year target. (Bullish)
• Federal proposals to impose Medicaid work requirements, allow ACA enhanced premium tax credits to expire, and accelerate Medicaid redeterminations pose a concentrated payer-mix risk to CYH given its high government-pay patient concentration across rural and semi-urban markets, with management already flagging these as active monitoring items on the Q1 2026 call. (Bearish)

Red Flags

[Securities Fraud / Investigation] The DOJ issued a Civil Investigative Demand to CYH seeking documents related to utilization review, inpatient admissions practices, and inpatient dialysis billing at its hospitals, causing the stock to fall ~28% on the disclosure date. — Community Health Systems 8-K / Healthcare Dive / Fierce Healthcare, February 2024

[Securities Fraud / Investigation] Multiple plaintiff firms filed or announced securities fraud class actions alleging CYH and certain officers issued false or misleading statements and failed to disclose the company's exposure to the DOJ investigation of improper admissions and dialysis billing practices. — Glancy Prongay & Murray LLP (Feb 2024); Pomerantz LLP (Jul 2024); Schall Law Firm (Aug 2024), February–August 2024

[Securities Fraud / Investigation] A CYH-affiliated Fresno-area hospital system agreed to pay $32 million to settle DOJ allegations that it provided improper financial benefits to referring physicians in violation of the False Claims Act. — KVPR / DOJ, May 2025, May 2025